Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) announced it has been awarded a $500,000 grant from the Western Australian Government to accelerate the commercialisation of its world-first blood test for endometriosis, a condition affecting one in nine women globally.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) Managing Director Dr. Richard Lipscombe is interviewed about the most recent Quarterly Report and the pipeline of precision diagnostic tests in commercialisation phase.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, announced the following update on its business activities for the three months to 30 September 2025 and subsequent to the period end.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce it has expanded its collaborative research agreement with the University of Melbourne and the Royal Women's Hospital.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the appointment of Ms Vicki Robinson to its Board as an independent non-executive director, effective 14 October 2025.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the appointment of David Wood as Joint Company Secretary for Proteomics International, effective today.
In this episode of The Ellis Martin Report on Money Talk Radio, Ellis speaks with Dr. Amie Phinney, Strategy and Business Advisor at Defence Therapeutics Inc. (CNSX:DTC) (FRA:DTC) (OTCMKTS:DTCFF).
